{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:26:10Z","timestamp":1790717170374,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,16]]},"DOI":"10.7759\/cureus.82379","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T15:29:36Z","timestamp":1744817376000},"source":"Crossref","is-referenced-by-count":1,"title":["Effective Treatment of Macrophage Activation Syndrome Linked to Systemic Lupus Erythematosus Using Interleukin-1 Inhibitor"],"prefix":"10.7759","author":[{"given":"Nur","family":"Barlas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikwinder P","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine","family":"Kuzhuppilly Arcilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurjit S","family":"Kaeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myint","family":"Thway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39332","article-title":"2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","volume":"68","author":"Ravelli A","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, et al.. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 2016, 68:566-76. 10.1002\/art.39332","journal-title":"Arthritis Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24883","article-title":"Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients","volume":"60","author":"Parodi A","year":"2009","unstructured":"Parodi A, Dav\u00ec S, Pringe AB, et al.. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum. 2009, 60:3388-99. 10.1002\/art.24883","journal-title":"Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.05.010","article-title":"Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients","volume":"16","author":"Gavand PE","year":"2017","unstructured":"Gavand PE, Serio I, Arnaud L, et al.. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients. Autoimmun Rev. 2017, 16:743-9. 10.1016\/j.autrev.2017.05.010","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne CB","year":"2019","unstructured":"Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of macrophage activation syndrome. Front Immunol. 2019, 10:119. 10.3389\/fimmu.2019.00119","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000381996.69261.71","article-title":"Macrophage activation syndrome: advances towards understanding pathogenesis","volume":"22","author":"Grom AA","year":"2010","unstructured":"Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol. 2010, 22:561-6. 10.1097\/01.bor.0000381996.69261.71","journal-title":"Curr Opin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.41103","article-title":"Benefit of Anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis","volume":"72","author":"Eloseily EM","year":"2020","unstructured":"Eloseily EM, Weiser P, Crayne CB, et al.. Benefit of Anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2020, 72:326-34. 10.1002\/art.41103","journal-title":"Arthritis Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP4ZDKJ4ICOUAT","article-title":"Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis","volume":"139","author":"Rosado FG","year":"2013","unstructured":"Rosado FG, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013, 139:713-27. 10.1309\/AJCP4ZDKJ4ICOUAT","journal-title":"Am J Clin Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos GC","year":"2011","unstructured":"Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011, 365:2110-21. 10.1056\/NEJMra1100359","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken342","article-title":"Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases","volume":"47","author":"Fukaya S","year":"2008","unstructured":"Fukaya S, Yasuda S, Hashimoto T, et al.. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford). 2008, 47:1686-91. 10.1093\/rheumatology\/ken342","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/294041","article-title":"Macrophage activation syndrome as onset of systemic lupus erythematosus: a case report and a review of the literature","volume":"2015","author":"Granata G","year":"2015","unstructured":"Granata G, Didona D, Stifano G, Feola A, Granata M. Macrophage activation syndrome as onset of systemic lupus erythematosus: a case report and a review of the literature. Case Rep Med. 2015, 2015:294041. 10.1155\/2015\/294041","journal-title":"Case Rep Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-019-0309-6","article-title":"Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome","volume":"17","author":"Halyabar O","year":"2019","unstructured":"Halyabar O, Chang MH, Schoettler ML, et al.. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Pediatr Rheumatol Online J. 2019, 17:7. 10.1186\/s12969-019-0309-6","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/art.40417","article-title":"Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus","volume":"70","author":"Borgia RE","year":"2018","unstructured":"Borgia RE, Gerstein M, Levy DM, Silverman ED, Hiraki LT. Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol. 2018, 70:616-24. 10.1002\/art.40417","journal-title":"Arthritis Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2019.19150","article-title":"Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg","volume":"7","author":"Crayne C","year":"2020","unstructured":"Crayne C, Cron RQ. Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg. Eur J Rheumatol. 2020, 7:S13-20. 10.5152\/eurjrheum.2019.19150","journal-title":"Eur J Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.635080","article-title":"Case report: life-threatening macrophage activation syndrome with fulminant myocarditis successfully rescued by high dose intravenous Anakinra","volume":"8","author":"Meneghel A","year":"2020","unstructured":"Meneghel A, Martini G, Amigoni A, Pettenazzo A, Padalino M, Zulian F. Case report: life-threatening macrophage activation syndrome with fulminant myocarditis successfully rescued by high dose intravenous Anakinra. Front Pediatr. 2020, 8:635080. 10.3389\/fped.2020.635080","journal-title":"Front Pediatr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42968","article-title":"A novel therapy for a rare condition: continuous Anakinra infusion for a patient with macrophage activation syndrome","volume":"15","author":"Gullickson M","year":"2023","unstructured":"Gullickson M, Nichols L, Scheibe M. A novel therapy for a rare condition: continuous Anakinra infusion for a patient with macrophage activation syndrome. Cureus. 2023, 15:e42968. 10.7759\/cureus.42968","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121098","article-title":"Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome","volume":"40","author":"Kahn PJ","year":"2013","unstructured":"Kahn PJ, Cron RQ. Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome. J Rheumatol. 2013, 40:743-4. 10.3899\/jrheum.121098","journal-title":"J Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30096-5","article-title":"Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome","volume":"2","author":"Mehta P","year":"2020","unstructured":"Mehta P, Cron RQ, Hartwell J, Manson JJ, Tattersall RS. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol. 2020, 2:e358-67. 10.1016\/S2665-9913(20)30096-5","journal-title":"Lancet Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-020-0399-1","article-title":"Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"18","author":"Shimizu M","year":"2020","unstructured":"Shimizu M, Mizuta M, Okamoto N, et al.. Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2020, 18:2. 10.1186\/s12969-020-0399-1","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221108852","article-title":"Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus","volume":"31","author":"Dey S","year":"2022","unstructured":"Dey S, Roongta R, Mondal S, Haldar S, Sircar G, Ghosh B, Ghosh A. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus. Lupus. 2022, 31:1132-7. 10.1177\/09612033221108852","journal-title":"Lupus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/329589-effective-treatment-of-macrophage-activation-syndrome-linked-to-systemic-lupus-erythematosus-using-interleukin-1-inhibitor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T15:29:37Z","timestamp":1744817377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/329589-effective-treatment-of-macrophage-activation-syndrome-linked-to-systemic-lupus-erythematosus-using-interleukin-1-inhibitor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.82379","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}